Literature DB >> 29450215

Pulmonary Cavity From Mycobacterium malmoense in an HIV-Infected Patient: Complicated by Bronchopleural Fistula.

Eric Abston1, Harrison Farber1.   

Abstract

We present a case of M. malmoense and HIV co-infection complicated by aspergilloma leading to bronchopleural fistula with intractable pneumothorax and pleural aspergillosis, ultimately requiring surgical intervention. Treatment guidelines for M. malmoense are reviewed, literature regarding M. malmoense and HIV co-infection is reviewed, and the epidemiology of M. malmoense in North America is discussed.

Entities:  

Keywords:  HIV; Mycobacterium malmoense; bronchopleural fistula

Year:  2018        PMID： 29450215      PMCID： PMC5808789          DOI： 10.1093/ofid/ofy023

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  20 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

Review 4.  Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.

Authors:  Ramon Pigem; Mireia Cairó; Xavier Martínez-Lacasa; Daniel Irigoyen; Josep M Miró; Juan Acevedo; Javier Fernández; Mercè Alsina-Gibert
Journal:  J Am Acad Dermatol       Date:  2013-10       Impact factor: 11.527

5.  Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007.

Authors:  Mohammed Al Houqani; Frances Jamieson; Pamela Chedore; Mauli Mehta; Kevin May; Theodore K Marras
Journal:  Can Respir J       Date:  2011 Jan-Feb       Impact factor: 2.409

Review 6.  Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis.

Authors:  Roland Diel; Felix Ringshausen; Elvira Richter; Lutz Welker; Jochen Schmitz; Albert Nienhaus
Journal:  Chest       Date:  2017-04-28       Impact factor: 9.410

7.  Mycobacterium malmoense infections in the United States, January 1993 through June 1995.

Authors:  U T Buchholz; M M McNeil; L E Keyes; R C Good
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

8.  Mycobacterium malmoense: an easily missed pathogen.

Authors:  S E Hoffner; B Henriques; B Petrini; G Källenius
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

9.  First Canadian Reports of Cervical Adenitis Due to Mycobacterium Malmoense and a 10-year Review of Nontuberculous Mycobacterial Adenitis.

Authors:  Chris McCrossin; Tim Mailman
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

10.  Pulmonary disease due to Mycobacterium malmoense.

Authors:  N G Warren; B A Body; V A Silcox; J H Matthews
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.